We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize s... read more Featured Products: More products

Download Mobile App





PerkinElmer Demonstrates High-Throughput MSMS Dried Blood Spot Screening Solutions at Medlab Middle East 2021

By LabMedica International staff writers
Posted on 21 Jun 2021
PerkinElmer, Inc. More...
(Waltham, MA; USA) demonstrated its high-throughput MSMS dried blood spot screening solutions at the 2021 edition of Medlab Middle East, the leading medical laboratory exhibition in the region for over 20 years.

On display at the event was the PerkinElmer QSight 225 LC/MS/MS system developed uniquely for newborn screening with the option for tier 2 testing – using just a single heel-prick dried blood spot (DBS) card. The QSight system delivers a unique combination of self-cleaning MS/MS instrumentation that provides exceptional system uptime, a simple setup process, and easy-to-use database software that simplifies review and analysis - plus kits and reagents, training, and support. The QSight system includes a high capacity autosampler, precision binary pump, best in class MS detector, and easy to use instrument control and data analysis software that have been optimized to run hundreds of samples per day, for weeks at a time, to generate consistent results with minimum maintenance or downtime.

PerkinElmer also exhibited the Opera Phenix High Content Screening System, the premier confocal solution for today's most demanding high content applications. Drawing on over a decade of experience with the industry-leading Opera High Content Screening System, the Opera Phenix is designed for high-throughput, phenotypic screening and assays involving complex disease models, such as live cells, primary cells and microtissues. In addition, PerkinElmer highlighted the VICTOR Nivo multimode reader that breaks new ground, packing all popular detection modes into the industry’s smallest benchtop footprint. The successor to the highly popular VICTOR X system - the world’s first multimode plate reader - the VICTOR Nivo system detects absorbance, luminescence, fluorescence intensity, time-resolved fluorescence, fluorescence polarization and now Alpha technologies, making it perfect for everyday biochemical and cell-based assays, including kinetic measurements.

At this year’s Medlab Middle East, PerkinElmer displayed the LC 300 chromatography platform that redefines and simplifies LC, delivering the flexibility, performance, and efficiency to tackle challenging analytical demands. Users can choose between a 10k-psi system for HPLC and an 18k-psi system for ultraprecise UHPLC analysis. Both offer patented valve technology and sample handling options to accommodate multiple sample tray formats. And SimplicityChrom 21CFR11 software delivers intuitive instrument control, while an integrated color display shows immediate system status. Combined with CDS third-party drivers for commercial systems, this offers a powerful and simple LC solution. Also on display was the chemagic 360 instrument, with dimensions of only 80 x 80 cm and its unique sample volume flexibility, making it the ideal solution for nucleic acid isolation in human genetics, biobanking, HLA typing, viral and bacterial detection.

Related Links:
PerkinElmer, Inc.


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The liquid biopsy approach measures randomness in DNA methylation patterns to detect early-stage cancer signals in blood (Photo courtesy of 123RF)

Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability

Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.